Technical Description
The present invention provides a novel multifunctional hybrid molecule for the treatment of neurodegenerative diseases. It is a hybrid of N-benzylpiperidine and 5-(2,4-dichlorophenyl)-1,3,4-oxadiazole for the treatment of Alzheimer’s disease
Problems Addressed
- Aβ Accumulation in Brain
- Decreased Cholinergic Activity
- Limitations of Existing Treatments
- Monofunctional Molecules
Tech Features
- Multifunctional Molecules
- Inhibits Cholinesterases & BACE-1
- High Melting Point
- Low IC50 Value
- Novel Compound
- Anti-Aβ Aggregation Activity
- Low Toxicity
Target Audience
- Healthcare & Medical Sector
- Pharmaceutical Industry
- Biotechnology Firms
- Research and Development
Tech ID: P27-1239 TRL 5 Patent Status: Granted Available For Exclusive and Non-exclusive License
